Article
PD-1/LAG-3 Dysfunctionality Signatures in Human Cancers
2023-03-15
Abstract excerpt
<h4>ABSTRACT</h4> A significant number of cancer patients do not benefit from PD-L1/PD-1 blockade immunotherapies. PD-1 and LAG-3 co-upregulation in T-cells is one of the major mechanisms of resistance by establishing a highly dysfunctional state in T-cells. To identify shared features associated to PD- 1/LAG-3 dysfunctionality in human cancers and T-cells, multiomic expression profiles were obtained for all TCGA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 041f8af8-6029-5682-9fd3-d5a8e23db6eb
- DOI
- 10.1101/2023.03.10.23287087
